Cohort 3. Rome | ||
Baseline characteristic | pSS | Sicca |
Age (years)* | 48 (26,72) | 55 (37,70) |
Female† | 15/17 (88.2) | 15/15 (100) |
Anti-Ro antibody positive† | 11/17 (64.7) | 0/0 (100) |
Anti-La antibody positive† | 8/17 (47.1) | 0/0 (100) |
Anti-nuclear antibody positive† | 12/17 (70.6) | 0/0 (100) |
Hyperglobulinemia† | 7/17 (41.2) | 0/0 (100) |
Focus score* | 2.8 (1,10) | N/A |
Germinal centre† | 11/17 (64.7) | N/A |
ESSDAI* | 1 (0, 7) | 0 (0, 2) |
*Median (range).
†Number positive (%).
BAFF, B cell activating factor; ESSDAI, EULAR Sjögren’s Syndrome Disease Activity Index; Ig, immunoglobulin; pSS, primary Sjögren’s syndrome.